9,422 followers
Phase II trial exploring use of neoadjuvant #socazolimab combined with chemotherapy for locally advanced esophageal squamous cell carcinoma ( #ESCC) demonstrate promising major pathological response (MPR) and pathological complete response (pCR) rates: h